Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


Articles published in Cancer Epidemiol Biomarkers Prev

Retrieve available abstracts of 127 articles:
HTML format



Single Articles


    June 2024
  1. LOHANI KR, Nibbe AM, Vierkant RA, Pacheco-Spann LM, et al
    Understanding benign breast disease and subsequent breast cancer in Hispanic white females; a step closer to evidence-based management.
    Cancer Epidemiol Biomarkers Prev. 2024 Jun 5. doi: 10.1158/1055-9965.EPI-24-0204
    PubMed     Abstract available


  2. YAGHJYAN L, Wang Z, Warner ET, Rosner B, et al
    Reproductive Factors Related to Childbearing and a Novel Automated Mammographic Measure, V.
    Cancer Epidemiol Biomarkers Prev. 2024;33:804-811.
    PubMed     Abstract available


    May 2024
  3. YE Z, Nguyen TL, Dite GS, Maclnnis RJ, et al
    Mammographic texture versus conventional Cumulus measure of density in breast cancer risk prediction: a literature review.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  4. FREEMAN JQ, Huo D
    Addressing Social Determinants in the Era of Precision Medicine in Breast Cancer: Is It Sufficient to Reduce Disparities?
    Cancer Epidemiol Biomarkers Prev. 2024;33:635-637.
    PubMed     Abstract available


  5. JATOI I
    Breast Cancer Screening: Can We Justify Deescalation?
    Cancer Epidemiol Biomarkers Prev. 2024;33:638-640.
    PubMed     Abstract available


  6. PARK JE, Smith MA, Van Alsten SC, Walens A, et al
    Diffsig: Associating Risk Factors with Mutational Signatures.
    Cancer Epidemiol Biomarkers Prev. 2024;33:721-730.
    PubMed     Abstract available


  7. VAN ALSTEN SC, Dunn MR, Hamilton AM, Ivory JM, et al
    Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status.
    Cancer Epidemiol Biomarkers Prev. 2024;33:654-661.
    PubMed     Abstract available


    April 2024
  8. PARADA H, Wu T, Hoh E, Rock CL, et al
    Red Blood Cell Polyunsaturated Fatty Acids and Mortality Following Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  9. COLLISTER JA, Liu X, Littlejohns TJ, Cuzick J, et al
    Assessing the value of incorporating a polygenic risk score with non-genetic factors for predicting breast cancer diagnosis in the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  10. MOSS JL, Geyer NR, Lengerich EJ
    Patterns of Cancer-Related Healthcare Access across Pennsylvania: Analysis of Novel Census Tract-Level Indicators of Persistent Poverty.
    Cancer Epidemiol Biomarkers Prev. 2024;33:616-623.
    PubMed     Abstract available


  11. BARBER LE, McCullough LE, Johnson DA
    Eyes Wide Open: Sleep as a Potential Contributor to Racial and Ethnic Disparities in Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024;33:471-479.
    PubMed     Abstract available


  12. HAN E, Van Horn L, Snetselaar L, Shepherd JA, et al
    The Associations between Intakes of One-Carbon Metabolism-Related Vitamins and Breast Density among Young Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:567-575.
    PubMed     Abstract available


    March 2024
  13. SIEGEL SD, Zhang Y, Lynch SM, Rowland J, et al
    A Novel Approach for Conducting a Catchment Area Analysis of Breast Cancer by Age and Stage for a Community Cancer Center.
    Cancer Epidemiol Biomarkers Prev. 2024 Mar 7. doi: 10.1158/1055-9965.EPI-23-1125
    PubMed     Abstract available


  14. LEE M, Kotake R, Yamauchi H
    Physical Activity and Mammographic Density in Japanese Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:365-370.
    PubMed     Abstract available


    February 2024
  15. FARBER R, Houssami N, McGeechan K, Barratt A, et al
    Breast cancer stage and size detected with film versus digital mammography in New South Wales, Australia: a population-based study using routinely collected data.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  16. ANDERSEN HH, Bojesen SE, Johansen JS, Ejlertsen B, et al
    Prognostic Value of Pre-treatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  17. UONG SP, Torres JM, Alexeeff SE, Morey BN, et al
    Differences in Smoking Behavior by Nativity, Race/Ethnicity, and Education Among Women Diagnosed with Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  18. DEVASIA TP, Howlader N, Dewar RA, Stevens JL, et al
    Increase in the Life Expectancy of Patients with Cancer in the United States.
    Cancer Epidemiol Biomarkers Prev. 2024;33:196-205.
    PubMed     Abstract available


  19. PEILA R, Rohan TE
    Metabolic Syndrome and the Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2024;33:333-336.
    PubMed     Abstract available


    January 2024
  20. ZELDIN J, Sandler DP, Ogunsina K, O'Brien KM, et al
    Association of fibroids, endometriosis, and gynecologic surgeries with breast cancer incidence and hormone receptor subtypes.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


    December 2023
  21. AIELLO BOWLES EJ, Kroenke CH, Chubak J, Bhimani J, et al
    Evaluation of algorithms using automated health plan data to identify breast cancer recurrences.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  22. GARDUNO-ALANIS A, Angeles-Llerenas A, Sanchez-Zamorano LM, Flores-Luna L, et al
    Sugar-sweetened beverage consumption and breast cancer in pre- and post-menopausal women.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  23. YE Z, Dite GS, Nguyen TL, Maclnnis RJ, et al
    Genetic and environmental causes of variation in an automated breast cancer risk factor based on mammographic textures.
    Cancer Epidemiol Biomarkers Prev. 2023 Dec 7. doi: 10.1158/1055-9965.EPI-23-1012
    PubMed     Abstract available


  24. TRAN TXM, Kim S, Park B
    Mammographic Breast Density and Risk of Ovarian Cancer in Korean Women.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1690-1698.
    PubMed     Abstract available


  25. HODGE JM, Patel AV, Islami F, Jemal A, et al
    Educational Attainment and Cancer Incidence in a Large Nationwide Prospective Cohort.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1747-1755.
    PubMed     Abstract available


    November 2023
  26. LORONA NC, Othus M, Malone KE, Linden HM, et al
    Alcohol, smoking, and risks of breast cancer recurrence and mortality among women with luminal, triple-negative, and HER2-overexpressing breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  27. LORD SJ, Daniels B, O'Connell DL, Kiely BE, et al
    Decline in the incidence of distant recurrence of breast cancer: A population-based health record linkage study, Australia 2001-2016.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  28. GOLDFINGER E, Stoler J, Goel N
    A multi-scale space-time epidemiological analysis of neighborhood correlates of triple negative breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  29. PETERS BA, Kelly L, Wang T, Loudig O, et al
    The breast microbiome in breast cancer risk and progression: a narrative review.
    Cancer Epidemiol Biomarkers Prev. 2023 Nov 9. doi: 10.1158/1055-9965.EPI-23-0965
    PubMed     Abstract available


  30. TEHRANIFAR P, Bertrand KA
    Enhancing Mammography and Empowering Solutions for Breast Cancer Disparities.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1479-1481.
    PubMed     Abstract available


  31. CHATTERJEE N, Dun Y
    From Hazard Rate to Age-at-Onset Distribution: Mind the Gap.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1477-1478.
    PubMed     Abstract available


  32. NYANTE SJ, Abraham L, Aiello Bowles EJ, Lee CI, et al
    Racial and Ethnic Variation in Diagnostic Mammography Performance among Women Reporting a Breast Lump.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1542-1551.
    PubMed     Abstract available


  33. HUBBARD RA, Pujol TA, Alhajjar E, Edoh K, et al
    Sources of Disparities in Surveillance Mammography Performance and Risk-Guided Recommendations for Supplemental Breast Imaging: A Simulation Study.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1531-1541.
    PubMed     Abstract available


  34. KERLIKOWSKE K, Bissell MCS, Sprague BL, Tice JA, et al
    Impact of BMI on Prevalence of Dense Breasts by Race and Ethnicity.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1524-1530.
    PubMed     Abstract available


    October 2023
  35. HASHIBE M, Wei M, Lee CJ, Tao R, et al
    Incident Cardiovascular Disease Risk Among Older Asian, Native Hawaiian and Pacific Islander Breast Cancer Survivors.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  36. KOTSOPOULOS J, Hathaway CA, Narod SA, Teras LR, et al
    Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based Cohorts.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1402-1410.
    PubMed     Abstract available


  37. KEHM RD, Lilge L, Walter EJ, White M, et al
    Socioeconomic Status at Birth and Breast Tissue Composition in Adolescence and Adulthood.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1294-1301.
    PubMed     Abstract available


    September 2023
  38. ERGAS IJ, Bradshaw PT, Cespedes Feliciano EM, Roh JM, et al
    Hypothetical interventions on diet quality and lifestyle factors to improve breast cancer survival: the Pathways Study.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  39. MARIOTTO AB, Botta L, Bernasconi A, Zou Z, et al
    Prediction of risk of metastatic recurrence for female breast cancer patients in the presence of competing causes of death.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


    August 2023
  40. KAUR M, Patterson A, Molina-Vega J, Rothschild H, et al
    Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1107-1113.
    PubMed     Abstract available


    July 2023
  41. KORIC A, Mark B, Chang CP, Lloyd S, et al
    Adverse Health Outcomes Among Rural And Urban Breast Cancer Survivors: A Population-Based Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Jul 18:EPI-23-0421.
    PubMed     Abstract available


  42. HERBACH EL, Nash SH, Lizarraga IM, Carnahan RM, et al
    Patterns of evidence-based care for the diagnosis, staging, and first-line treatment of breast cancer by race-ethnicity: a SEER-Medicare study.
    Cancer Epidemiol Biomarkers Prev. 2023 Jul 12:EPI-23-0218.
    PubMed     Abstract available


    June 2023
  43. CHOI J, Ha TW, Choi HM, Lee HB, et al
    Development of a breast cancer risk prediction model incorporating polygenic risk scores and non-genetic risk factors for Korean women.
    Cancer Epidemiol Biomarkers Prev. 2023 Jun 13:EPI-23-0064.
    PubMed     Abstract available


    April 2023
  44. TROESCHEL AN, Hartman TJ, McCullough LE, Ergas IJ, et al
    Associations of post-diagnosis lifestyle with prognosis in women with invasive breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2023 Apr 20:EPI-22-1274.
    PubMed     Abstract available


    March 2023
  45. MEYER DS, Millen AE, Nie J, Trevisan M, et al
    Dietary fats and all-cause and breast cancer specific mortality among women with breast cancer: The Western New York Exposures and Breast Cancer (WEB) Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Mar 30:EPI-22-0881.
    PubMed     Abstract available


  46. LOU MW, Drummond AE, Swain CT, Milne RL, et al
    Linking physical activity to breast cancer via inflammation, Part 2: The effect of inflammation on breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2023 Mar 3:EPI-22-0929.
    PubMed     Abstract available


  47. SWAIN CT, Drummond AE, Milne RL, English DR, et al
    Linking physical activity to breast cancer risk via inflammation, Part 1: The effect of physical activity on inflammation.
    Cancer Epidemiol Biomarkers Prev. 2023 Mar 3:EPI-22-0928.
    PubMed     Abstract available


    February 2023
  48. MUSE ME, Carroll CD, Salas LA, Karagas MR, et al
    Application of novel breast biospecimen cell type adjustment identifies shared DNA methylation alterations in breast tissue and milk with breast cancer risk factors.
    Cancer Epidemiol Biomarkers Prev. 2023 Feb 10:EPI-22-0405.
    PubMed     Abstract available


  49. JOHN EM, Koo J, Ingles SA, Kurian AW, et al
    Changes in breast cancer risk and risk factor profiles among U.S.-born and immigrant Asian American women residing in the San Francisco Bay Area.
    Cancer Epidemiol Biomarkers Prev. 2023 Feb 10:EPI-22-1128.
    PubMed     Abstract available


  50. ROSENZWEIG MQ, Mazanec SR
    Racial Differences in Breast Cancer Therapeutic Toxicity: Implications for Practice.
    Cancer Epidemiol Biomarkers Prev. 2023;32:157-158.
    PubMed     Abstract available


  51. DE HAAN-DU J, Groenier KH, Wauben-Spaetgens B, Jalving M, et al
    The Value of Glycemic Control Prior to Cancer Diagnosis on All-Cause Mortality among Patients with Type 2 Diabetes in Dutch Primary Care.
    Cancer Epidemiol Biomarkers Prev. 2023;32:252-259.
    PubMed     Abstract available


    January 2023
  52. SU YR, Buist DS, Lee JM, Ichikawa L, et al
    Performance of statistical and machine learning risk prediction models for surveillance benefits and failures in breast cancer survivors.
    Cancer Epidemiol Biomarkers Prev. 2023 Jan 25:EPI-22-0677.
    PubMed     Abstract available


  53. YASUI Y, Letsou W, Wang F, Im C, et al
    Inference on the Genetic Architecture of Breast Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2023 Jan 18:EPI-22-1073.
    PubMed     Abstract available


  54. MAVADDAT N, Ficorella L, Carver T, Lee A, et al
    Incorporating alternative Polygenic Risk Scores into the BOADICEA breast cancer risk prediction model.
    Cancer Epidemiol Biomarkers Prev. 2023 Jan 13:EPI-22-0756.
    PubMed     Abstract available


    December 2022
  55. NARII N, Kito K, Sobue T, Zha L, et al
    Acrylamide and glycidamide hemoglobin adduct levels and breast cancer risk in Japanese women: A nested case-control study in the JPHC.
    Cancer Epidemiol Biomarkers Prev. 2022 Dec 16:EPI-22-0904.
    PubMed     Abstract available


  56. SWAIN CTV, Drummond AE, Milne RL, English DR, et al
    Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2106-2115.
    PubMed     Abstract available


  57. DRUMMOND AE, Swain CTV, Milne RL, English DR, et al
    Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2116-2125.
    PubMed     Abstract available


    November 2022

  58. Correction: Cognitive Impairment in Patients with Breast Cancer before Surgery: Results from a CANTO Cohort Subgroup.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2092.
    PubMed    


  59. DUCHESNEAU ED, Jackson BE, Webster-Clark M, Lund JL, et al
    The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2079-2086.
    PubMed     Abstract available


    October 2022
  60. MACCIOTTA A, Catalano A, Giraudo MT, Weiderpass E, et al
    Mediating role of lifestyle behaviours in the association between education and cancer: results from the European Prospective Investigation into Cancer and Nutrition.
    Cancer Epidemiol Biomarkers Prev. 2022 Oct 28. pii: 710109.
    PubMed     Abstract available


  61. HVIDTFELDT UA, Chen J, Rodopoulou S, Strak M, et al
    Breast cancer incidence in relation to long-term low-level exposure to air pollution in the ELAPSE pooled cohort.
    Cancer Epidemiol Biomarkers Prev. 2022 Oct 10. pii: 709688.
    PubMed     Abstract available


  62. ASHI K, Ndom P, Gakwaya A, Makumbi T, et al
    Validation of the Nigerian Breast Cancer Study Model for Predicting Individual Breast Cancer Risk in Cameroon and Uganda.
    Cancer Epidemiol Biomarkers Prev. 2022 Oct 10. pii: 709687.
    PubMed     Abstract available


    September 2022
  63. HU X, Kaplan CM, Martin MY, Walker MS, et al
    Race differences in patient-reported symptoms during chemotherapy among women with early-stage hormone receptor positive breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 27. pii: 709495.
    PubMed     Abstract available


  64. WALENS A, Van Alsten SC, Olsson LT, Smith MA, et al
    RNA-based classification of homologous recombination deficiency in racially-diverse patients with breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 21. pii: 709340.
    PubMed     Abstract available


  65. CROSS T, George A, Attwood K, Zhang Y, et al
    Associations between Serum 25-hydroxyvitamin D Levels and Health-Related Quality-of-Life Measures in Breast Cancer Patients: A Longitudinal Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 20. pii: 709294.
    PubMed     Abstract available


  66. YE H, Tang LY, Liang ZZ, Chen QX, et al
    Effects of infection-induced fever and the interaction with interleukin-6 rs1800796 polymorphism on the prognosis of breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 9. pii: 709164.
    PubMed     Abstract available


  67. BAZAN JG, Obeng-Gyasi S
    Disparities in Early-Stage Breast Cancer and Survival-Letter.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1867.
    PubMed    


  68. PRIMM KM, Zhao H, Hernandez DC, Chang S, et al
    Disparities in Early-Stage Breast Cancer and Survival-Reply.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1868.
    PubMed    


    August 2022
  69. OLSSON LT, Walens A, Hamilton AM, Fleming JM, et al
    Obesity and Breast Cancer Metastasis Across Genomic Subtypes.
    Cancer Epidemiol Biomarkers Prev. 2022 Aug 16. pii: 707899.
    PubMed     Abstract available


  70. WANG T, Heng YJ, Baker GM, Bret-Mounet VC, et al
    Loss of PTEN Expression, PIK3CA Mutations, and Breast Cancer Survival in the Nurses' Health Studies.
    Cancer Epidemiol Biomarkers Prev. 2022 Aug 1. pii: 707366.
    PubMed     Abstract available


    July 2022
  71. KORN AR, Reedy J, Brockton NT, Kahle LL, et al
    The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and cancer risk: a longitudinal analysis in the NIH-AARP Diet and Health Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Jul 25. pii: 707213.
    PubMed     Abstract available


  72. WALLNER LP, Chen LH, Hogan TA, Brasfield FM, et al
    The influence of medical comorbidities on survival disparities in a multi-ethnic group of patients with de novo metastatic breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Jul 21. pii: 707116.
    PubMed     Abstract available


  73. NORMANN AJ, Kang DW, Christopher CN, Norris MK, et al
    Improved Sleep Quality Is Associated with Reduced Insulin Resistance in Cancer Survivors Undertaking Circuit, Interval-Based Exercise.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1509-1510.
    PubMed     Abstract available


  74. BENASHLEY LW, Bucy AM, Wertheim BC, Blew R, et al
    Paclitaxel Treatment Effects on Neurofilament Light Chain (NF-L), a Possible Biomarker of Chemotherapy-Induced Peripheral Neuropathy (CIPN).
    Cancer Epidemiol Biomarkers Prev. 2022;31:1510-1511.
    PubMed     Abstract available


  75. BALLINGER TJ, Djuric Z, Sardesai S, Hovey K, et al
    Proton Pump Inhibitor Use and Obesity-Associated Cancers in the Women's Health Initiative.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1511.
    PubMed     Abstract available


  76. LECOMPTE CG, McDougall J, Walters ST, Toppmeyer D, et al
    Understanding Cancer Genetic Risk Assessment Intentions in a Tailored Risk Communication Intervention Randomized Controlled Trial.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1513-1514.
    PubMed     Abstract available


  77. BELLISSIMO MP, Canada JM, Jordan JH, Ladd AC, et al
    Changes in Physical Activity, Functional Capacity, and Cardiac Function during Breast Cancer Therapy.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1509.
    PubMed     Abstract available


  78. NYANTE SJ, Abraham L, Aiello Bowles EJ, Lee CI, et al
    Diagnostic Mammography Performance across Racial and Ethnic Groups in a National Network of Community-Based Breast Imaging Facilities.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1324-1333.
    PubMed     Abstract available


  79. BARNARD ME, Martheswaran T, Van Meter M, Buys SS, et al
    Body Mass Index and Mammographic Density in a Multiracial and Multiethnic Population-Based Study.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1313-1323.
    PubMed     Abstract available


  80. LESSER C, Mericq V, Reyes M, Garmendia ML, et al
    Habitual Phytoestrogen Intake Is Associated with Breast Composition in Girls at 2 Years after Menarche Onset.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1334-1340.
    PubMed     Abstract available


  81. PEILA R, Rohan TE
    Association of Prediagnostic Serum Levels of Vitamin D with Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1499-1502.
    PubMed     Abstract available


    June 2022
  82. AHEARN TU, Pal Choudhury P, Derkach A, Wiafe-Addai B, et al
    Breast cancer risk in women from Ghana carrying rare germline pathogenic mutations.
    Cancer Epidemiol Biomarkers Prev. 2022 Jun 2. pii: 699329.
    PubMed     Abstract available


  83. ROSNER B, Glynn RJ, Eliassen AH, Hankinson SE, et al
    A multi-state survival model for time to breast cancer mortality among a cohort of initially disease-free women.
    Cancer Epidemiol Biomarkers Prev. 2022 Jun 2. pii: 699326.
    PubMed     Abstract available


  84. ZAVALA VA, Casavilca-Zambrano S, Navarro Vasquez J, Castaneda CA, et al
    Association between ancestry-specific 6q25 variants and breast cancer subtypes in Peruvian women.
    Cancer Epidemiol Biomarkers Prev. 2022 Jun 2. pii: 699327.
    PubMed     Abstract available


  85. BRADLEY CJ, Sabik LM, Entwistle J, Stevens JL, et al
    Role of Medicaid in Early Detection of Screening-Amenable Cancers.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1202-1208.
    PubMed     Abstract available


    May 2022
  86. MCWILLIAMS L, Groves S, Howell SJ, French DP, et al
    The impact of morbidity and disability on attendance at organised breast cancer screening programmes: A systematic review and meta-analysis.
    Cancer Epidemiol Biomarkers Prev. 2022 May 5. pii: 696307.
    PubMed     Abstract available


  87. MENDOZA JA, Miller CA, Martin KJ, Resnicow K, et al
    Examining the Association of Food Insecurity and Being Up-to-Date for Breast and Colorectal Cancer Screenings.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1017-1025.
    PubMed     Abstract available


    April 2022
  88. KOTSOPOULOS J, Lubinski J, Gronwald J, Menkiszak J, et al
    Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: a Reappraisal.
    Cancer Epidemiol Biomarkers Prev. 2022 Apr 27. pii: 694788.
    PubMed     Abstract available


  89. HAMILTON AM, Hurson AN, Olsson LT, Walens A, et al
    The landscape of immune microenvironments in racially-diverse breast cancer patients.
    Cancer Epidemiol Biomarkers Prev. 2022 Apr 18. pii: 694482.
    PubMed     Abstract available


  90. WANG X, Cho-Phan CD, Hoskins KF, Calip GS, et al
    Understanding Racial and Ethnic Inequities in Uptake and Outcomes Following Multigene Prognostic Testing in Early Breast Cancer: The Promise of Real-World Data.
    Cancer Epidemiol Biomarkers Prev. 2022;31:704-706.
    PubMed     Abstract available


    March 2022
  91. PRIMM KM, Zhao H, Hernandez DC, Chang S, et al
    A contemporary analysis of racial and ethnic disparities in diagnosis of early stage breast cancer and stage-specific survival by molecular subtype.
    Cancer Epidemiol Biomarkers Prev. 2022 Mar 21. pii: 682328.
    PubMed     Abstract available


  92. PALA V, Agnoli C, Cavalleri A, Rinaldi S, et al
    Pre-diagnostic levels of copper and zinc and breast cancer risk in the ORDET cohort.
    Cancer Epidemiol Biomarkers Prev. 2022 Mar 4. pii: 682049.
    PubMed     Abstract available


  93. NGUYEN SM, Tran HT, Nguyen LM, Bui OT, et al
    Association of fruit, vegetable and animal food intakes with breast cancer risk overall and by molecular subtype among Vietnamese women.
    Cancer Epidemiol Biomarkers Prev. 2022 Mar 3. pii: 682000.
    PubMed     Abstract available


  94. MCDONALD JA, Vilfranc CL, Terry MB
    The Epidemiology of Pregnancy-Related Breast Cancers: Are We Ready to Deliver?
    Cancer Epidemiol Biomarkers Prev. 2022;31:518-520.
    PubMed     Abstract available


  95. HASLAM DE, John EM, Knight JA, Li Z, et al
    Diet Quality and All-Cause Mortality in Women with Breast Cancer from the Breast Cancer Family Registry.
    Cancer Epidemiol Biomarkers Prev. 2022 Mar 1:EPI-22-1198.
    PubMed     Abstract available


    February 2022
  96. HOLDER EX, Houghton SC, Sanchez SS, Eliassen AH, et al
    Estrogenic activity and risk of invasive breast cancer among postmenopausal women in the Nurses' Health Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Feb 7. pii: 1055-9965.EPI-21-1157.
    PubMed     Abstract available


    January 2022
  97. MOORE J, Wang F, Pal T, Reid S, et al
    Oncotype DX Risk Recurrence Score and Total Mortality for Early-Stage Breast Cancer by Race/Ethnicity.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 21. pii: 1055-9965.EPI-21-0929.
    PubMed     Abstract available


  98. BRANTLEY KD, Zeleznik OA, Rosner B, Tamimi RM, et al
    Plasma Metabolomics and Breast Cancer Risk Over 20 Years of Follow-up Among Postmenopausal Women in the Nurses' Health Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 21. pii: 1055-9965.EPI-21-1023.
    PubMed     Abstract available


  99. STRANDBERG R, Czene K, Eriksson M, Hall P, et al
    Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 13. pii: 1055-9965.EPI-21-1011.
    PubMed     Abstract available


  100. NAIR RG, Lee SJC, Berry E, Argenbright KE, et al
    Long-term Mammography Adherence among Uninsured Women Enrolled in the Breast Screening and Patient Navigation (BSPAN) Program.
    Cancer Epidemiol Biomarkers Prev. 2022;31:77-84.
    PubMed     Abstract available


    December 2021
  101. PEILA R, Arthur RS, Dannenberg AJ, Rohan TE, et al
    Association of a healthy lifestyle index with risk of breast cancer among women with normal body mass index in the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2021 Dec 21. pii: 1055-9965.EPI-21-0765.
    PubMed     Abstract available


  102. NIEHOFF NM, Terry MB, Bookwalter DB, Kaufman JD, et al
    Air pollution and breast cancer: an examination of modification by underlying familial breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2021 Dec 14. pii: 1055-9965.EPI-21-1140.
    PubMed     Abstract available


  103. CONNOR AE, Kaur M, Dibble KE, Visvanathan K, et al
    Racialized economic segregation and breast cancer mortality among women in Maryland.
    Cancer Epidemiol Biomarkers Prev. 2021 Dec 3. pii: 1055-9965.EPI-21-0923.
    PubMed     Abstract available


  104. TIN TIN S, Key TJ, Reeves GK
    Alcohol Intake and Endogenous Hormones in Pre- and Postmenopausal Women: Findings from the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2021;30:2294-2301.
    PubMed     Abstract available


    November 2021
  105. VOHRA SN, Walens A, Hamilton AM, Sherman ME, et al
    Molecular and clinical characterization of postpartum-associated breast cancer in the Carolina Breast Cancer Study Phase I-III, 1993-2013.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 22. pii: 1055-9965.EPI-21-0940.
    PubMed     Abstract available


  106. NAZARIO CM, Rosario-Rosado RV, Schelske-Santos M, Mansilla-Rivera I, et al
    Sun exposure is associated with reduced breast cancer risk among women living in the Caribbean: The Atabey study in Puerto Rico.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 22. pii: 1055-9965.EPI-21-0932.
    PubMed     Abstract available


  107. CHARVAT H, Freisling H, Noh H, Gaudet MM, et al
    Excess body fatness during early to mid-adulthood and survival from colorectal and breast cancer: a pooled analysis of five international cohort studies.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 15. pii: 1055-9965.EPI-21-0688.
    PubMed     Abstract available


  108. SIEGEL SD, Brooks MM, Sims-Mourtada J, Schug ZT, et al
    A Population Health Assessment in a Community Cancer Center Catchment Area: Triple negative breast cancer, alcohol use, and obesity in New Castle County, Delaware.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 4. pii: 1055-9965.EPI-21-1031.
    PubMed     Abstract available


  109. HURSON AN, Abubakar M, Hamilton AM, Conway K, et al
    TP53 pathway function, estrogen receptor status, and breast cancer risk factors in the Carolina Breast Cancer Study.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 4. pii: 1055-9965.EPI-21-0661.
    PubMed     Abstract available


  110. MARIOTTO AB, Zhang F, Buckman DW, Miller D, et al
    Characterizing Trends in Cancer Patients' Survival Using the JPSurv Software.
    Cancer Epidemiol Biomarkers Prev. 2021;30:2001-2009.
    PubMed     Abstract available


    October 2021
  111. DONG W, Bensken WP, Kim U, Rose J, et al
    Phenotype Discovery and Geographic Disparities of Late-Stage Breast Cancer Diagnosis across U.S. Counties: A Machine Learning Approach.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 25. pii: 1055-9965.EPI-21-0838.
    PubMed     Abstract available


  112. PENG C, Zeleznik OA, Shutta KH, Rosner BA, et al
    A Metabolomics Analysis of Circulating Carotenoids and Breast Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 25. pii: 1055-9965.EPI-21-0837.
    PubMed     Abstract available


  113. ZHANG X, Wolff MS, Shen J, Parada H, et al
    Phthalates and Phenols, Leukocyte Telomere Length, and Breast Cancer Risk and Mortality in the Long Island Breast Cancer Study Project.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 25. pii: 1055-9965.EPI-21-0830.
    PubMed     Abstract available


  114. LYNCH BM, Milne RL, English DR, Brown KA, et al
    Linking physical activity to breast cancer: text mining results and a protocol for systematically reviewing three potential mechanistic pathways.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 20. pii: 1055-9965.EPI-21-0435.
    PubMed     Abstract available


  115. DRUMMOND AE, Swain CTV, Brown KA, Dixon-Suen SC, et al
    Linking physical activity to breast cancer via sex steroid hormones Part 2: The effect of sex steroid hormones on breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 20. pii: 1055-9965.EPI-21-0438.
    PubMed     Abstract available


  116. SWAIN CTV, Drummond AE, Boing L, Milne RL, et al
    Linking physical activity to breast cancer via sex hormones part 1: The effect of physical activity on sex steroid hormones.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 20. pii: 1055-9965.EPI-21-0437.
    PubMed     Abstract available


    September 2021
  117. TAN VY, Bull CJ, Biernacka KM, Teumer A, et al
    Investigation of the interplay between circulating lipids and IGF-I and relevance to breast cancer risk: an observational and Mendelian randomization study.
    Cancer Epidemiol Biomarkers Prev. 2021 Sep 28. pii: 1055-9965.EPI-21-0315.
    PubMed     Abstract available


  118. OMOFUMA OO, Peterson LL, Turner DP, Merchant AT, et al
    Dietary Advanced Glycation End-Products (AGEs) and Mortality After Breast Cancer in the Women's Health Initiative (WHI).
    Cancer Epidemiol Biomarkers Prev. 2021 Sep 28. pii: 1055-9965.EPI-21-0610.
    PubMed     Abstract available


    August 2021
  119. BARON JA, Nichols HB, Anderson C, Safe S, et al
    Cigarette Smoking and Estrogen-Related Cancer.
    Cancer Epidemiol Biomarkers Prev. 2021;30:1462-1471.
    PubMed     Abstract available


    June 2021
  120. PEILA R, Chlebowski R, Manson JE, Crane TE, et al
    Low-fat dietary modification and risk of ductal carcinoma in situ of the breast in the Women's Health Initiative Dietary Modification trial.
    Cancer Epidemiol Biomarkers Prev. 2021 Jun 29. pii: 1055-9965.EPI-21-0404.
    PubMed     Abstract available


    May 2021
  121. DIMOU N, Yarmolinsky J, Bouras E, Tsilidis KK, et al
    Causal Effects of Lifetime Smoking on Breast and Colorectal Cancer Risk: Mendelian Randomization Study.
    Cancer Epidemiol Biomarkers Prev. 2021;30:953-964.
    PubMed     Abstract available


  122. WILSON LF, Tuesley KM, Webb PM, Dixon-Suen SC, et al
    Hysterectomy and Risk of Breast, Colorectal, Thyroid, and Kidney Cancer - an Australian Data Linkage Study.
    Cancer Epidemiol Biomarkers Prev. 2021;30:904-911.
    PubMed     Abstract available


    April 2021
  123. SHEPPARD VB, Sutton AL, Hurtado-de-Mendoza A, He J, et al
    Race and Patient-reported Symptoms in Adherence to Adjuvant Endocrine Therapy: A Report from the Women's Hormonal Initiation and Persistence Study.
    Cancer Epidemiol Biomarkers Prev. 2021;30:699-709.
    PubMed     Abstract available


    March 2021
  124. CARVER T, Hartley S, Lee A, Cunningham AP, et al
    CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants.
    Cancer Epidemiol Biomarkers Prev. 2021;30:469-473.
    PubMed     Abstract available


    January 2021
  125. BENEFIELD HC, Zirpoli GR, Allott EH, Shan Y, et al
    Epidemiology of Basal-like and Luminal Breast Cancers among Black Women in the AMBER Consortium.
    Cancer Epidemiol Biomarkers Prev. 2021;30:71-79.
    PubMed     Abstract available


  126. SPRAGUE BL, Vacek PM, Mulrow SE, Evans MF, et al
    Collagen Organization in Relation to Ductal Carcinoma In Situ Pathology and Outcomes.
    Cancer Epidemiol Biomarkers Prev. 2021;30:80-88.
    PubMed     Abstract available


    August 2020
  127. GAGLIARDI A, Dugue PA, Nost TH, Southey MC, et al
    Stochastic epigenetic mutations are associated with risk of breast cancer, lung cancer and mature B-cell neoplasms.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 11. pii: 1055-9965.EPI-20-0451.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.